REVELATION BIOSCIENCES, INC. (REVB)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 3 signals for REVELATION BIOSCIENCES, INC.. Most notable: 2026-06-24: Filed 8-K disclosing director or officer change; 2026-08-19: Filed 8-K disclosing director or officer change; 2026-07-13: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-30 | Rolke James | director | F | 10,115 | 1.13 | $11,430 |
| 2026-04-30 | Zygmont Chester Stanley III | officer | F | 13,285 | 1.1 | $14,614 |
| 2026-02-04 | Zygmont Chester Stanley III | officer | F | 13,100 | 1.65 | $21,615 |
| 2026-02-03 | ROPER JESS | director | F | 1,591 | 1.85 | $2,943 |
| 2026-02-03 | Chawla Lakhmir S | director | F | 2,261 | 1.85 | $4,183 |
| 2026-02-03 | CARVER JENNIFER | director | F | 1,661 | 1.87 | $3,106 |
| 2026-02-03 | Rolke James | director | F | 8,521 | 1.86 | $15,849 |
| 2026-01-08 | Rolke James | director | A | 532,829 | 0.9 | $479,546 |
| 2026-01-08 | Zygmont Chester Stanley III | officer | A | 78,145 | 0.9 | $70,331 |
| 2026-01-08 | CARVER JENNIFER | director | A | 41,981 | 0.9 | $37,783 |
| 2026-01-08 | ROPER JESS | director | A | 41,981 | 0.9 | $37,783 |
| 2026-01-08 | Chawla Lakhmir S | director | A | 41,981 | 0.9 | $37,783 |
| 2025-10-29 | Chawla Lakhmir S | director | A | 15,625 | 1.28 | $20,000 |
| 2025-10-29 | Rolke James | director | A | 390,614 | 1.28 | $499,986 |
| 2025-10-29 | CARVER JENNIFER | director | A | 15,625 | 1.28 | $20,000 |
| 2025-10-29 | Zygmont Chester Stanley III | officer | A | 390,614 | 1.28 | $499,986 |
| 2025-10-29 | ROPER JESS | director | A | 15,625 | 1.28 | $20,000 |
| 2025-02-11 | Chawla Lakhmir S | director | A | 181 | 3.87 | $700 |
| 2025-02-11 | CARVER JENNIFER | director | A | 181 | 3.87 | $700 |
| 2025-02-11 | ROPER JESS | director | A | 181 | 3.87 | $700 |
| 2025-02-11 | Rolke James | director | A | 30,095 | 3.87 | $116,468 |
| 2025-02-11 | Zygmont Chester Stanley III | officer | A | 15,048 | 3.87 | $58,236 |
| 2025-02-11 | TIDMARSH GEORGE F | director | A | 181 | 3.87 | $700 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.